0
0
Read Time:9 Second
Lupin Limited has informed the Exchange regarding a press release dated December 01, 2025, titled “Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg (Pegfilgrastim-unne)”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %